Medical Research Company Announces Milestone Results For Autism Disorder

SciSparc's Leap Forward in Autism Research: First Patient Enrolled in Crucial Clinical Trial.

As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.

In a significant milestone for autism research, SciSparc Ltd. (NASDAQ: $SPRC) recently announced the enrollment of its first patient for a clinical trial aimed at children with Autism Spectrum Disorder (ASD). T…